Roche Acquires Good Therapeutics for US$250 M Upfront

By Lucy Haggerty

Pharma Deals Review: Vol 2022 Issue 9 (Table of Contents)

Published: 10 Sep-2022

DOI: 10.3833/pdr.v2022.i9.2720     ISSN: 1756-7874

Section: Mergers & Acquisitions



In an attempt to strengthen its cancer immunotherapy pipeline, Roche has entered into a definitive merger agreement to acquire Good Therapeutics for an upfront payment of US$250 M as well as further potential milestone payments...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details